CGRP monoclonal antibody LY2951742 for the prevention of migraine: a phase 2, randomized, double-blind, placebo-controlled study

被引：0
|
作者：
Goadsby, P. [1 ,2 ,3 ]
Dodick, D. [4 ]
Spierings, E. [5 ,6 ,7 ]
Scherer, J. [8 ]
Sweeney, S. [9 ]
Grayzel, D. [9 ]
机构：
[1] Kings Coll London, NIHR Wellcome Trust Clin Res Facil KCL, London WC2R 2LS, England
[2] Kings Coll London, Dept Neurol UCSF, London WC2R 2LS, England
[3] Univ Calif San Francisco, London, England
[4] Mayo Clin, Dept Neurol, Phoenix, AZ USA
[5] Harvard Univ, Brigham & Womens Hosp, Dept Neurol BWH, Sch Med, Boston, MA 02115 USA
[6] Harvard Univ, Brigham & Womens Hosp, Headache & Face Pain Program, Sch Med, Boston, MA 02115 USA
[7] Tufts Sch Dent Med, Boston, MA USA
[8] Eli Lilly & Co, Indianapolis, IN 46285 USA
[9] Arteaus Therapeut, Cambridge, MA USA
来源：
JOURNAL OF HEADACHE AND PAIN | 2014年 / 15卷
关键词：
Placebo; Migraine; Calcitonin; Injection Site; Secondary Endpoint;
D O I：
10.1186/1129-2377-15-S1-G10
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EHMTI-0178
引用
收藏
页数：1
相关论文
共 50 条
  • [41] S-fluoxetine in the prophylaxis of migraine: a phase II double-blind randomized placebo-controlled study
    Steiner, TJ
    Ahmed, F
    Findley, LJ
    MacGregor, EA
    Wilkinson, M
    CEPHALALGIA, 1998, 18 (05) : 283 - 286
  • [42] Response to topiramate in the prevention of chronic migraine: results of a double-blind, randomized, placebo-controlled trial
    Grazzi, L.
    Diener, H-C
    Van Oene, J. C.
    Lahaye, M.
    Schwalen, S.
    Goadsby, P. J.
    CEPHALALGIA, 2006, 26 (11) : 1368 - 1368
  • [43] Remote electrical neuromodulation for migraine prevention: A double-blind, randomized, placebo-controlled clinical trial
    Tepper, Stewart J.
    Rabany, Liron
    Cowan, Robert P.
    Smith, Timothy R.
    Grosberg, Brian M.
    Torphy, Bradley D.
    Harris, Dagan
    Vizel, Maya
    Ironi, Alon
    Stark-Inbar, Alit
    Blumenfeld, Andrew M.
    HEADACHE, 2023, 63 (03): : 377 - 389
  • [44] Magnesium in the prophylaxis of migraine - A double-blind, placebo-controlled study
    Pfaffenrath, V
    Wessely, P
    Meyer, C
    Isler, HR
    Evers, S
    Grotemeyer, KH
    Taneri, Z
    Soyka, D
    Gobel, H
    Fischer, M
    CEPHALALGIA, 1996, 16 (06) : 436 - 440
  • [45] VERAPAMIL PROPHYLAXIS OF MIGRAINE - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    SOLOMON, GD
    STEEL, JG
    SPACCAVENTO, LJ
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1983, 250 (18): : 2500 - 2502
  • [46] Prevention of COPD exacerbation by lysozyme: a double-blind, randomized, placebo-controlled study
    Fukuchi, Yoshinosuke
    Tatsumi, Koichiro
    Inoue, Hiromasa
    Sakata, Yukinori
    Shibata, Kai
    Miyagishi, Hideaki
    Marukawa, Yasuhiro
    Ichinose, Masakazu
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2016, 11 : 831 - 838
  • [47] Baseline Population Characteristics of PROMISE-2: A Phase 3, Randomized, Double-blind, Placebo-Controlled Study of Eptinezumab for Prevention of Chronic Migraine
    Spierings, E. L. H.
    Khan, A.
    Cady, R.
    Schaeffler, B.
    Bhattacharya, S.
    Biondi, D.
    Hirman, J.
    Smith, J.
    HEADACHE, 2018, 58 : 98 - 99
  • [48] Efficacy of coenzyme Q10 for the prevention of migraine in women: A randomized, double-blind, placebo-controlled study
    Dahri, Monireh
    Hashemilar, Mazyar
    Asghari-Jafarabadi, Mohammad
    Tarighat-Esfanjani, Ali
    EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE, 2017, 16 : 8 - 14
  • [49] Quality of life measures from a large, randomized, double-blind, placebo-controlled study of Topiramate in migraine prevention
    Diamond, M
    Neto, W
    Jacobs, D
    Fairclough, D
    Wolfe, P
    Papadopoulous, G
    CEPHALALGIA, 2003, 23 (07) : 710 - 710
  • [50] Almotriptan for acute treatment of migraine: a randomized, double-blind, placebo-controlled study in Korea
    Chung, C. S.
    Park, K. Y.
    Moon, H. S.
    Joo, S. A.
    Song, K. S.
    Kim, J. A.
    CEPHALALGIA, 2006, 26 (11) : 1392 - 1392
12345